PG4
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 15
Of
15
Go to page
1
September 01, 2026
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
(clinicaltrials.gov)
- P3 | N=4670 | Not yet recruiting | Sponsor: Pfizer
New P3 trial • Infectious Disease • Pneumococcal Infections
June 23, 2026
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
(clinicaltrials.gov)
- P3 | N=1200 | Recruiting | Sponsor: Pfizer
New P3 trial • Infectious Disease • Pneumococcal Infections
June 06, 2026
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
(clinicaltrials.gov)
- P3 | N=3230 | Recruiting | Sponsor: Pfizer
New P3 trial • Infectious Disease • Pneumococcal Infections
May 28, 2026
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
(clinicaltrials.gov)
- P3 | N=2400 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Pneumococcal Infections
May 08, 2026
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
(clinicaltrials.gov)
- P3 | N=2400 | Not yet recruiting | Sponsor: Pfizer
New P3 trial • Infectious Disease • Pneumococcal Infections
April 09, 2026
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
(clinicaltrials.gov)
- P1 | N=380 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Pneumococcal Infections • Pneumonia
March 12, 2026
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
(clinicaltrials.gov)
- P2 | N=225 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Pneumococcal Infections
September 09, 2025
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
(clinicaltrials.gov)
- P2 | N=605 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Pneumococcal Infections
August 18, 2025
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
(clinicaltrials.gov)
- P1 | N=372 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Pneumococcal Infections • Pneumonia
July 26, 2025
A Study to Learn About How a New Pneumococcal Vaccine Works in Adults
(clinicaltrials.gov)
- P1 | N=372 | Not yet recruiting | Sponsor: Pfizer
New P1 trial • Infectious Disease • Pneumococcal Infections • Pneumonia
July 03, 2025
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
(clinicaltrials.gov)
- P2 | N=225 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting | Trial completion date: Sep 2025 ➔ Feb 2026 | Trial primary completion date: Sep 2025 ➔ Feb 2026
Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Pneumococcal Infections
April 02, 2025
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
(clinicaltrials.gov)
- P2 | N=800 | Recruiting | Sponsor: Pfizer | N=500 ➔ 800 | Trial completion date: Aug 2026 ➔ May 2027 | Trial primary completion date: Aug 2026 ➔ May 2027
Enrollment change • Trial completion date • Trial primary completion date • Infectious Disease • Pneumococcal Infections
August 07, 2024
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
(clinicaltrials.gov)
- P2 | N=300 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Pneumococcal vaccines • Infectious Disease • Pneumococcal Infections
August 07, 2024
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
(clinicaltrials.gov)
- P2 | N=400 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Pneumococcal vaccines • Infectious Disease • Pneumococcal Infections
August 01, 2024
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
(clinicaltrials.gov)
- P2 | N=300 | Not yet recruiting | Sponsor: Pfizer
New P2 trial • Pneumococcal vaccines • Infectious Disease • Pneumococcal Infections
1 to 15
Of
15
Go to page
1